• MARKET ANALYSIS (PACIFIC EDGE)

    MARKET ANALYSIS (PACIFIC EDGE)
    Pacific Edge develops novel diagnostic technologies for the early detection and monitoring of cancer. Scarlatti has undertaken a variety of research and market validation studies for Pacific Edge relating both to its own technologies and to in-licensing opportunities.

  • MARKET ANALYSIS OF A NOVEL DAIRY BIOACTIVE (NEW ZEALAND DAIRY COMPANY)

    MARKET ANALYSIS OF A NOVEL DAIRY BIOACTIVE (NEW ZEALAND DAIRY COMPANY)
    Scarlatti worked to conduct a market validation study to inform the commercialisation plan and targeted sales and marketing campaign for a novel dairy bioactive. This work was carried out for a New Zealand dairy processor who sought to explore the commercial options for this technology.

  • FINANCIAL MODEL AND BUSINESS PLAN (GENAVIA THERAPEUTICS)

    FINANCIAL MODEL AND BUSINESS PLAN (GENAVIA THERAPEUTICS)
    Genavia was a start-up bio-tech venture whose business plan featured considerable market and technical risk along with an opportunity for spectacular returns. Scarlatti developed a financial model that dealt with this uncertainty and assigned probabilities and value projections to the extensive range of potential outcomes. This allowed Genavia to communicate appropriately the potential risks and returns from its business plan to investors.

  • ANIMAL BIO-IMAGING FEASIBILITY STUDY (AGRESEARCH & THE LIGGINS INSTITUTE)

    ANIMAL BIO-IMAGING FEASIBILITY STUDY (AGRESEARCH & THE LIGGINS INSTITUTE)
    Scarlatti performed a comprehensive feasibility study to investigate the potential of using advanced bio-imaging technologies to improve outcomes in the New Zealand pastoral agriculture sector. The study was conducted in association with experts from AgResearch (Crown Research Institute) and the Liggins Institute (University of Auckland)and funded by the New Zealand government's Foundation for Research, Science and Technology (FRST).